Author

Alexandra Dopfer‐Jablonka

Medizinische Hochschule HannoverORCID 0000-0001-7129-100XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

Georg M. N. BehrensiD· 3 shared Inga NehlmeieriD· 3 shared Markus HoffmanniD· 3 shared Amy Madeleine Kempf· 2 shared Christine HappleiD· 2 shared Lu ZhangiD· 2 shared Luise Graichen· 2 shared Metodi V. StankoviD· 2 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Georg M. N. BehrensORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintOct 8, 2026

Epidemiology and virological characteristics of the emerging SARS-CoV-2 variant PJ.2.1

Markus Hoffmann, Lu Zhang, Nianzhen Chen…·Stefan Poehlmann

The paper characterizes the epidemiology and virology of the SARS-CoV-2 variant PJ.2.1, finding it spreads mainly in older adults and shows increased ACE2 binding but not greater antibody evasion.

DOI 10.64898/2026.10.08.757354

virusexperimental assay

𝕏 PostBluesky

Molecular BiologyThe Lancet Infectious DiseasesPeer-reviewedNov 7, 2024

Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC

Prerna Arora, Christine Happle, Amy Madeleine Kempf…·Markus Hoffmann

The paper characterizes the XEC SARS-CoV-2 lineage and evaluates the neutralization effect of JN.1 booster vaccination against KP.3.1.1 and XEC variants.

45 citationstop 1%

experimental assay

𝕏 PostBluesky

Molecular BiologyVaccinesPeer-reviewedMay 1, 2024

Virological traits of the SARS-CoV-2 BA.2.87.1 lineage

Lu Zhang, Alexandra Dopfer‐Jablonka, Inga Nehlmeier…·Markus Hoffmann

This study investigates the virological traits of the SARS-CoV-2 BA.2.87.1 lineage, finding it efficiently enters human cells but is more sensitive to antibody neutralization than JN.1.

8 citations

humanexperimental assay

𝕏 PostBluesky